Improving HPV vaccination rates among young girls in Nigeria
Implementation Penetration Assessment Criteria Tool for HPV Vaccination- Promoting Uptake among Young Girls in Nigeria
This study is looking at how to help more teenage girls in Nigeria get the HPV vaccine by figuring out what makes it easier or harder for them to get vaccinated in their communities.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10998613 on NIH RePORTER |
What this research studies
This research aims to address the gap between available HPV vaccines and their uptake among adolescent girls in Nigeria. It focuses on developing tools to assess and enhance the integration of HPV vaccination into community practices and policies. By identifying key factors that influence vaccination penetration, the project seeks to create a framework that can be easily implemented in resource-limited settings. The approach involves understanding community dynamics and perceptions to promote better vaccination rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women in Nigeria who are eligible for HPV vaccination.
Not a fit: Patients outside of Nigeria or those who are not within the target age group for HPV vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among young girls, leading to reduced cervical cancer incidence in the future.
How similar studies have performed: Similar research efforts in other regions have shown promise in improving vaccination rates through community engagement and tailored interventions.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Anikamadu, Onyekachukwu — Washington University
- Study coordinator: Anikamadu, Onyekachukwu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.